Sign Up for Vincent AI
Janssen Inc. v. Apotex Inc.,
1 cases
Apotex Inc. v. Janssen Inc.,
"...In an action pursuant to the Patented Medicines (Notice of Compliance) Regulations, S.O.R./93-133 (the Regulations), the Federal Court (2022 FC 996, per Justice Christine M. Pallotta) agreed with the respondents’ allegation and enjoined Apotex from various activities involving Apo-Ma..."
Try vLex and Vincent AI for free
Start a free trial3 firm's commentaries
2022 Year In Review: IP Litigation
"...a generic drug manufacturer is said to induce prescribing physicians (Janssen Inc v Apotex Inc, 2022 FC 107; Janssen Inc v Apotex Inc, 2022 FC 996; and Janssen Inc v Pharmascience, 2022 FC 62). Similarly, in UPL NA Inc v AgraCity Crop & Nutrition Ltd, 2022 FC 1422, an action for patent infr..."
Canadian Patent Law: 2022 Year In Review
"...the claimed subject matter was not obvious to try and Pharmascience's obviousness defence failed. The decision of Janssen v Apotex, ( 2022 FC 996) related to infringement via inducement. The patent at issue claimed, generally speaking, the use of the active ingredient macitentan in combinat..."
Janssen Succeeds On Infringement Against Apotex In Macitentan Combination Patent Case
"...Apotex would infringe Janssen's patent relating to Janssen's OPSUMIT (macitentan) by selling APO-MACITENTAN: Janssen Inc v Apotex Inc, 2022 FC 996. Apotex did not challenge Canadian Patent No. 2,659,770 (770 Patent) was the subject of an earlier s. 6(1) action involving Janssen and Sandoz, ..."
Try vLex and Vincent AI for free
Start a free trialExperience vLex's unparalleled legal AI
Access millions of documents and let Vincent AI power your research, drafting, and document analysis — all in one platform.
Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
1 cases
Apotex Inc. v. Janssen Inc.,
"...In an action pursuant to the Patented Medicines (Notice of Compliance) Regulations, S.O.R./93-133 (the Regulations), the Federal Court (2022 FC 996, per Justice Christine M. Pallotta) agreed with the respondents’ allegation and enjoined Apotex from various activities involving Apo-Ma..."
Try vLex and Vincent AI for free
Start a free trialStart Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
3 firm's commentaries
2022 Year In Review: IP Litigation
"...a generic drug manufacturer is said to induce prescribing physicians (Janssen Inc v Apotex Inc, 2022 FC 107; Janssen Inc v Apotex Inc, 2022 FC 996; and Janssen Inc v Pharmascience, 2022 FC 62). Similarly, in UPL NA Inc v AgraCity Crop & Nutrition Ltd, 2022 FC 1422, an action for patent infr..."
Canadian Patent Law: 2022 Year In Review
"...the claimed subject matter was not obvious to try and Pharmascience's obviousness defence failed. The decision of Janssen v Apotex, ( 2022 FC 996) related to infringement via inducement. The patent at issue claimed, generally speaking, the use of the active ingredient macitentan in combinat..."
Janssen Succeeds On Infringement Against Apotex In Macitentan Combination Patent Case
"...Apotex would infringe Janssen's patent relating to Janssen's OPSUMIT (macitentan) by selling APO-MACITENTAN: Janssen Inc v Apotex Inc, 2022 FC 996. Apotex did not challenge Canadian Patent No. 2,659,770 (770 Patent) was the subject of an earlier s. 6(1) action involving Janssen and Sandoz, ..."